Efficacy and safety of nivolumab in asian patients with advanced hepatocellular carcinoma (HCC): Subanalysis of the CheckMate 040 Study

被引：0
|
作者：
Choo, S. P. [1 ]
Yau, T. [2 ]
Hsu, C. [3 ,4 ]
Kang, Y-K. [5 ]
Hou, M-M. [6 ]
Yeo, W. [7 ]
Numata, K. [8 ]
Chopra, A. [9 ]
Baakili, A. [10 ]
Dela Cruz, C. [10 ]
Zhao, H. [10 ]
Kudo, M. [11 ]
机构：
[1] Natl Canc Ctr Singapore, Med Oncol, Singapore, Singapore
[2] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[5] Univ Ulsan, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[6] Chang Gung Mem Hosp, Dept Internal Med, Taipei, Taiwan
[7] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[8] Yokohama City Univ, Med Ctr, Dept Gastroenterol Ctr, Yokohama, Kanagawa, Japan
[9] Johns Hopkins Singapore Int Med Ctr, Med Oncol, Singapore, Singapore
[10] Bristol Myers Squibb, Dept Oncol, Princeton, NJ USA
[11] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
195O
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Nivolumab in Asian Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study
    Kudo, Masatoshi
    Hsu, Chiun
    Kim, Tae-You
    Choo, Su-Pin
    Kang, Yoon-Koo
    Hou, Ming-Mo
    Yeo, Winnie
    Numata, Kazushi
    Chopra, Akhil
    Baakili, Adyb
    dela Cruz, Christine
    Zhao, Huanyu
    Yau, Thomas
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Efficacy and safety of nivolumab plus ipilimumab in Asian patients with advanced hepatocellular carcinoma: Subanalysis of the CheckMate 040 study
    Yau, T.
    Hsu, C.
    Kang, Y.
    Kim, T.
    Hou, M.
    Lim, H.
    Chao, Y.
    Kim, Y.
    Ikeda, M.
    Choo, S.
    Neely, J.
    Shen, Y.
    Tschaika, M.
    Kudo, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S233 - S233
  • [3] Nivolumab (Nivo) in Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): the CheckMate 040 Study
    Melero, Ignacio
    Sangro, Bruno
    Yau, Thomas
    Hsu, Chiun
    Kudo, Masatoshi
    Crocenzi, Todd S.
    Kim, Tae-You
    Choo, Su-pin
    Trojan, Jorg
    Meyer, Timothy
    Welling, Theodore
    Yeo, Winnie
    Chopra, Akhil
    Anderson, Jeffrey
    Delacruz, Christine
    Lang, Lixin
    Neely, Jaclyn
    Tang, Hao
    El-Khoueiry, Anthony B.
    HEPATOLOGY, 2016, 64 (06) : 1124A - 1124A
  • [4] Nivolumab dose escalation and expansion in patients with advanced hepatocellular carcinoma (HCC): The CheckMate 040 study.
    Melero, Ignacio
    Sangro, Bruno
    Yau, Thomas Cheung
    Hsu, Chiun
    Kudo, Masatoshi
    Crocenzi, Todd S.
    Kim, Tae-You
    Choo, SuPin
    Trojan, Jorg
    Meyer, Tim
    Welling, Theodore Hobart
    Yeo, Winnie
    Chopra, Akhil
    Anderson, Jeffrey
    Dela Cruz, Christine Marie
    Lang, Lixin
    Neely, Jaclyn
    Tang, Hao
    El-Khoueiry, Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [5] Nivolumab in sorafenib-naive and - experienced patients with advanced hepatocellular carcinoma (HCC): checkMate 040 study
    Trojan, J.
    Crocenzi, T. S.
    El-Khoueiry, A. B.
    Yau, T.
    Melero, I.
    Sangro, B.
    Kudo, M.
    Hsu, C.
    Kim, T. -Y.
    Choo, S. -P.
    Meyer, T.
    Kang, Y. -K.
    Yeo, W.
    Chopra, A.
    Baakili, A.
    dela Cruz, C.
    Lang, L.
    Neely, J.
    Welling, T. H.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 210 - +
  • [6] Efficacy and safety of nivolumab in patients with advanced hepatocellular carcinoma analyzed by patient age: A sub-analysis of the CheckMate 040 study
    Ignacio, Melero
    Anthony, El-Khoueiry
    Thomas, Yau
    Chiun, Hsu
    Masatoshi, Kudo
    Todd, Crocenzi
    Tae-You, Kim
    Su-Pin, Choo
    Joerg, Trojan
    Theodore, Welling
    Yoon-Koo, Kang
    Winnie, Yeo
    Akhil, Chopra
    Adyb, Baakili
    Christine, dela Cruz
    Zhao Huanyu
    Bruno, Sangro
    Tim, Meyer
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Sangro, Bruno
    Hsu, Chiun
    Kang, Yoon-Koo
    Kim, Tae-You
    El-Khoueiry, Anthony
    Santoro, Armando
    Melero, Ignacio
    Kudo, Masatoshi
    Hou, Ming-Mo
    Pena, Ana Matilla
    Tovoli, Francesco
    Knox, Jennifer J.
    He, Aiwu Ruth
    El-Rayes, Bassel
    Acosta, Mirelis Rivera
    Lim, Ho-Yeong
    Neely, Jaclyn
    Zhao, Huanyu
    Anderson, Jeffrey
    Yau, Thomas
    HEPATOLOGY, 2019, 70 : 131A - 132A
  • [8] Safety and preliminary efficacy of nivolumab in patients with advanced hepatocellular carcinoma: interim analysis of the phase 1/2 CheckMate-040 study
    Melero, I.
    Sangro, B.
    Yau, T.
    Hsu, C.
    Kudo, M.
    Crocenzi, T.
    Kim, T-Y.
    Choo, S. P.
    Trojan, J.
    Meyer, T.
    Welling, T. H., III
    Yeo, W.
    Chopra, A.
    Anderson, J.
    Dela Cruz, C.
    Lang, L.
    Neely, J.
    El-Khoueiry, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study
    Sangro, B.
    Yau, T.
    Hsu, C.
    Kudo, M.
    Crocenzi, T. S.
    Choo, S. -P.
    Meyer, T.
    Welling, T. H., III
    Yeo, W.
    Chopra, A.
    Baakili, A.
    Dela Cruz, C.
    Lang, L.
    Neely, J.
    Melero, I.
    El-Khoueiry, A. B.
    Trojan, J.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S34 - S35
  • [10] Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040
    Sangro, Bruno
    Melero, Ignacio
    Yau, Thomas
    Hsu, Chiun
    Kudo, Masatoshi
    Kim, Tae-You
    Choo, Su-Pin
    Trojan, Jorg
    Welling, Theodore H.
    Meyer, Timothy
    Kang, Yoon-Koo
    Yeo, Winnie
    Chopra, Akhil
    Baakili, Adyb
    dela Cruz, Christine
    Zhao, Huanyu
    Neely, Jaclyn
    Crocenzi, Todd S.
    El-Khoueiry, Anthony B.
    HEPATOLOGY, 2017, 66 : 82A - 82A
12345